|
TTLL5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.30819999996945E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.972600E-04 |
| Normal-vs-Stage2 |
9.08709999469792E-08 |
| Normal-vs-Stage3 |
1.66189999983857E-07 |
| Normal-vs-Stage4 |
1.655580E-01 |
| Stage1-vs-Stage2 |
2.300600E-03 |
| Stage1-vs-Stage3 |
6.559600E-04 |
| Stage1-vs-Stage4 |
8.720200E-01 |
| Stage2-vs-Stage3 |
7.611000E-01 |
| Stage2-vs-Stage4 |
2.970400E-01 |
| Stage3-vs-Stage4 |
3.552400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66383999999908E-05 |
| Normal-vs-AfricanAmerican |
5.101800E-03 |
| Normal-vs-Asian |
3.372800E-01 |
| Caucasian-vs-AfricanAmerican |
8.473200E-01 |
| Caucasian-vs-Asian |
3.351200E-01 |
| AfricanAmerican-vs-Asian |
5.949400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.74560000000468E-05 |
| Normal-vs-Female |
5.93420000000178E-05 |
| Male-vs-Female |
5.789600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.170400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.394490E-02 |
| Normal-vs-Age(61-80Yrs) |
5.41730005299002E-09 |
| Normal-vs-Age(81-100Yrs) |
4.238900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.310000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.835190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.534400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.120100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.200570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.797800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.680300E-02 |
| Normal-vs-Grade 2 |
3.775300E-04 |
| Normal-vs-Grade 3 |
7.11259999786051E-08 |
| Normal-vs-Grade 4 |
9.995500E-02 |
| Grade 1-vs-Grade 2 |
1.963880E-04 |
| Grade 1-vs-Grade 3 |
1.67945999999253E-05 |
| Grade 1-vs-Grade 4 |
6.223900E-03 |
| Grade 2-vs-Grade 3 |
1.957190E-03 |
| Grade 2-vs-Grade 4 |
6.264800E-01 |
| Grade 3-vs-Grade 4 |
7.612600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.37359999999809E-05 |
| Normal-vs-ccB subtype |
5.78950000051925E-07 |
| ccA subtype-vs-ccB subtype |
4.244400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.257800E-03 |
| Normal-vs-N1 |
3.79449999998727E-06 |
| N0-vs-N1 |
5.378900E-03 |
|
|
